Future Market Insights, Inc. (FMI) predicts a robust expansion of the urinary tract infection (UTI) treatment market, propelled by increasing infection rates, catheter use, and advancements in diagnosis and care. Dive deeper into the intricate dynamics of this burgeoning market and uncover compelling stakeholder opportunities in our comprehensive FMI report.
NEWARK, Del., Jan. 22, 2024 /PRNewswire/ — The Urinary Tract Infection (UTI) Treatment Market is estimated to be worth US$ 11,244.0 million in 2024 and is projected to be valued at US$ 13,617.4 million in 2034. Between 2024 and 2034, the industry is expected to register a growth rate of 1.9%.
Request Exclusive Sample Report: Urinary Tract Infection (UTI) Treatment Industry Strategic Insights, https://www.futuremarketinsights.com/reports/urinary-tract-infections-market
The urinary tract infection treatment market is poised for substantial growth in the foreseeable future, attributed to factors such as hormonal changes, inadequate personal hygiene practices, catheter usage, and other contributing factors. As the prevalence of urinary tract infections rises, the market is anticipated to experience noteworthy expansion in the coming years.
The heightened occurrence of chronic kidney diseases, including conditions like bladder cancer and renal failure, has resulted in a greater utilization of catheters and other drainage devices among patients. Individuals using urinary catheters face an elevated risk of developing complicated urinary tract infections, driving the demand for UTI treatment.
Supportive government policies, initiatives, and regulations can influence the market positively by fostering research and development in the field of UTI treatment. Increased spending on healthcare infrastructure and services, both in developed and developing countries, can positively influence the UTI treatment market.
The adoption of telehealth and remote patient monitoring technologies can facilitate better management and follow-up care for individuals with UTIs. Growing awareness among patients and healthcare professionals about the importance of early detection and prompt treatment of UTIs can contribute to market growth.
Urinary Tract Infection Treatment Market Research Report Scope
|
Attributes |
Details |
||
|
Estimated Market Size in 2024 |
US$ 11,244.0 million |
||
|
Projected Market Valuation in 2034 |
US$13,617.4 million |
||
|
Value-based CAGR 2024 to 2034 |
1.9 % |
||
|
Forecast Period |
2024 to 2034 |
||
|
Historical Data Available for |
2019 to 2023 |
||
|
Market Analysis |
Value in US$ million |
||
|
Key Market Segments Covered |
Urinary Tract Infection (UTI) Treatment Market – Key Segments • By Drug Class: o Penicillin & Combinations o Quinolones o Cephalosporin o Aminoglycoside Antibiotics o Sulphonamides (Sulfamethoxazole, Trimethoprim) o Azoles and Amphotericin B o Tetracycline (Doxycycline) o Nitrofurans (Nitrofurantoin) o Others • By Indication: o Complicated o Uncomplicated • By Distribution Channel: o Hospital Pharmacies o Gynecology and Urology Clinics o Drug Stores o Retail Pharmacies o Online Drug Stores • By Region: o North America o Latin America o Western Europe o Eastern Europe o South Asia and Pacific o East Asia o Middle East and Africa |
||
|
Key Countries Profiled |
|
|
|
Key Takeaways
- From 2019 to 2023, the urinary tract infection (UTI) treatment market was valued at a CAGR of 2.1%
- Based on indication, the uncomplicated UTI segment is expected to account for a share of 76.2% in 2024.
- Global urinary tract infection (UTI) treatment demand in China is predicted to account for a CAGR of 2.0% in 2024.
- In the United States, the urinary tract infection (UTI) treatment industry is expected to account for a CAGR of 2.5% in 2024.
- India is projected to expand by a value CAGR of 1.9% between 2024 and 2034.
- The urinary tract infection (UTI) treatment market in Japan is anticipated to record a CAGR of 2.1% in 2024.
“Increased prevalence of urinary tract infections and strategic advancements in treatment options propel the growth of the urinary tract infection treatment market.” says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).
Competitive Landscape
The market players are investing in ongoing research and development activities to discover and develop new and more effective UTI treatment options. This could involve the exploration of novel antibiotics, combination therapies, and innovative drug delivery methods. Expanding market presence by entering new geographic regions and enhancing distribution networks to ensure wider availability of UTI treatments.
Leading Companies in UTI Treatment Industry:
- Allergan
- Bayer AG
- Pfizer Inc.
- GlaxoSmithKline plc
- Bristol-Myers Squibb Company
- Janssen Global Services LLC
- Lupin Ltd
- Merck & Co. Inc.
- Almirall S.A
- Dr. Reddy’s Laboratories Ltd.
Purchase this report now to get key companies with their Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis.
Recent Developments:
- Bristol-Myers Squibb Company focuses on the development of drugs in various therapeutic areas, including infectious diseases. They might have products related to UTI treatment.
- Janssen Global Services LLC is a pharmaceutical company under the umbrella of Johnson & Johnson. They may have products related to infectious diseases, including UTI treatment.
- Lupin is an Indian multinational pharmaceutical company. They might have a range of pharmaceutical products, including those related to infectious diseases.
More Valuable Insights Available
Future Market Insights offers an unbiased analysis of the global urinary tract infection (UTI) treatment market, providing historical data from 2019 to 2023 and forecast statistics between 2024 and 2034.
To understand opportunities in the urinary tract infection (UTI) treatment industry, the industry is segmented based on Drug Class (Penicillin & Combinations, Quinolones, Cephalosporin, Aminoglycoside Antibiotics, Sulphonamides (Sulfamethoxazole, Trimethoprim), Azoles and Amphotericin B, Tetracycline (Doxycycline), Nitrofurans (Nitrofurantoin), Others) By Indication(Complicated Urinary Tract Infection, Uncomplicated Urinary Tract Infection) By Distribution Channel(Hospital Pharmacies, Gynecology and Urology Clinics, Drug Stores, Retail Pharmacies, Online Drug Stores) Region (North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, and the Middle East and Africa).
Request to Access the Detail Research Methodology from here!
About the Healthcare Division at Future Market Insights
The healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with the objective of providing authentic insights and accurate results to help clients worldwide.
With a repertoire of over 100+ reports and 1 billion+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the United Kingdom, the United States, and India. FMI’s latest market research reports and industry analysis helps businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
About the Author:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s Extensive Coverage in the Healthcare Domain:
- Urinary Tract Infection Testing Market by Urinalysis, Urine Cultures, and Susceptibility Testing, 2023-2033. – Review and Request to Access the Sample PDF.
- Uncomplicated Urinary Tract Infection Treatment Market by Drug Class, Distribution Channel & Region | Forecast 2023 to 2033. – Review and Request to Access the Sample PDF.
- Urinary Antibacterial and Antiseptic Pharmaceuticals Market: Global Industry Analysis and Opportunity Assessment 2022-2032. – Review and Request to Access the Sample PDF.
- Catheter Associated Urinary Tract Infections Treatment Market, Opportunities and Forecast, 2023-2033. – Review and Request to Access the Sample PDF.
- Podiatry Service Market Analysis by General, Sports, Cosmetic, and Orthopedic Services from 2024 to 2034. – Review and Request to Access the Sample PDF.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the United Kingdom, the United States, and India. FMI’s latest market research reports and industry analysis helps businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition.
Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/global-urinary-tract-infection-uti-treatment-market-is-expected-to-reach-us-13-617-4-million-by-2034–rising-at-a-1-9-cagr–fmi-study-302040588.html
Disclaimer: The above press release comes to you under an arrangement with PR Newswire. TheNewsThisWeek.co.uk takes no editorial responsibility for the same.